Back
Lucid Group, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
15
LCID
Lucid Group, Inc.
Last Price:
$12.76
Seasonality Move:
11.84%
Buy
57
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$105.07
Seasonality Move:
-6.7%
Sell
15
Lucid Group, Inc. (LCID)
is a Sell
Is Lucid Group, Inc. a Buy, Sell or Hold?
-
The current Lucid Group, Inc. [LCID] share price is $13.42. The Score for LCID is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
LCID is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.60. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LCID Stock Price Chart
What is Lucid Group, Inc.'s stock price today?
-
The Lucid Group, Inc. share price today is $13.42Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LCID is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $104.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
LCID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.21 | Sell |
| Relative Strength Index (14 RSI): | 40.21 | Sell |
| Chaikin Money Flow: | -8624928 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.6 - 16.62) | Sell |
| Bollinger Bands (100): | (15.73 - 24.73) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 50.78 | Buy |
| Chaikin Money Flow: | -195325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.6 - 107.92) | Buy |
| Bollinger Bands (100): | (92.83 - 106.97) | Buy |
LCID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.34 | Buy |
| 20-day SMA: | 13.96 | Sell |
| 50-day SMA: | 17.87 | Sell |
| 200-day SMA: | 21.87 | Sell |
| 8-day EMA: | 13.42 | Sell |
| 20-day EMA: | 14.22 | Sell |
| 50-day EMA: | 16.65 | Sell |
| 200-day EMA: | 21.79 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.83 | Sell |
| 20-day SMA: | 102.55 | Buy |
| 50-day SMA: | 104.26 | Buy |
| 200-day SMA: | 80.37 | Buy |
| 8-day EMA: | 104.76 | Sell |
| 20-day EMA: | 104.28 | Buy |
| 50-day EMA: | 102.89 | Buy |
| 200-day EMA: | 85.54 | Buy |
Lucid Group, Inc. Earnings Growth & LCID Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.09 per share, and an increase next year of $2.62 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.66 per share.
Lucid Group, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||